Page 2 - Jay Gertz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ligand Reports First Quarter 2021 Financial Results Search jobs Conference Call Begins at 4:30 p.m. Eastern Time Today SAN DIEGO (BUSINESS WIRE) $LGND#earnings Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2021 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions. “This year has opened strong for Ligand with solid financial performance and great results from all of our core technology platforms,” said John Higgins, Chief Executive Officer. “We are very pleased to report a smooth and efficient integration of the four acquisitions we closed last year. Our R&D team has expanded considerably and we are reaping the benefits of these transactions with more licensing deals and contract revenue. Working within a highly dynamic and unpredictable COVID-19 landscape, we

John higginsValentino stellaJay gertzBruce vossAcrotech biopharmaBaxter internationalJazz pharmaceuticalsUniversity of utahPelican expression technologySerum institute of indiaCstone pharmaceuticalsGilead sciencesLigand pharmaceuticalsLigand pharmaceuticals incorporatedHuntsman cancer instituteEuropean commission